Today: 30 June 2026
Browse Category

NASDAQ:VRAX 18 May 2026 - 19 May 2026

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Group shares were higher again in early U.S. premarket trading Tuesday after a big move Monday. The thinly traded diagnostics micro-cap saw a spike in turnover as investors kept looking for a new catalyst. The Nasdaq stock traded at $0.2751 at 5:00 a.m. EDT, 17.1% higher than where it finished Monday. Shares closed last session at $0.2350, up 53.1%, with about 765.2 million shares crossed. The 52-week range is $0.10 to $1.19, so it’s still priced in penny-stock territory.
19 May 2026
···
Why Virax Biolabs Stock Is Jumping Before the Bell Today

Why Virax Biolabs Stock Is Jumping Before the Bell Today

Virax Biolabs Group Limited shares were indicated sharply higher before the Nasdaq open on Monday, adding to a gain at Friday’s close, after the microcap diagnostics company appeared in a weekend sponsored television segment and a fresh ownership filing hit the tape. The move matters because Virax is a thinly valued, low-priced stock. StockAnalysis showed the shares closed Friday at $0.1535, up 9.64%, and were indicated at $0.3458 in pre-market trading at 8:59 a.m. EDT on Monday. Its market value at Friday’s close was about $3.06 million.
18 May 2026
·

Stock Market Today

  • Questerre preferred shares start trading on Euronext Growth
    June 30, 2026, 12:40 AM EDT. Questerre Energy opened trading for its preferred shares on Euronext Growth on June 30, 2026. The launch gives Questerre a way to tap European markets and broaden capital options. The preferred shares come with fixed dividends and rank above common shares for payouts and liquidation. No distribution is planned in the U.S., keeping with regulatory rules. Questerre is offering a new way for investors to get exposure as it adjusts its financing strategy in shifting market conditions.
Go toTop